Prelude Capital Management’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $222K | Buy |
+64,813
| New | +$222K | 0.02% | 753 |
|
|
2024
Q3 | – | Sell |
-120,900
| Closed | -$358K | – | 1136 |
|
|
2024
Q2 | $358K | Buy |
+120,900
| New | +$358K | 0.02% | 634 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 1442 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 1574 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 1309 |
|